Us Bancorp »

Contineum Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0k 123 16.39

More positions owned by Us Bancorp

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core Msci Eafe (IEFA)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
Amazon (AMZN)
Ishares Tr Rus Mid Cap Etf (IWR)
JPMorgan Chase & Co. (JPM)

View all positions for Us Bancorp

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Jupiter Topco
Henderson Group
BlackRock
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Vanguard Capital Management
Perceptive Advisors
FMR
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Ikarian Capital
Sectoral Asset Management

View all funds holding Contineum Therapeutics